Á lódáil...
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
The discovery of Epidermal Growth Factor Receptor (EGFR) mutations in Non Small Cell Lung Cancer (NSCLC) launched the era of personalized medicine in advanced NSCLC, leading to a dramatic shift in the therapeutic landscape of this disease. After ten years from the individuation of activating mutatio...
Na minha lista:
Foilsithe in: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Impact Journals LLC
2015
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4694955/ https://ncbi.nlm.nih.gov/pubmed/26308162 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|